FDA inspection
Tiger Medical Group: FDA inspection ending May 22, 2014
FDA inspection 883912 · Voluntary Action Indicated (VAI) · Shanghai
Key facts
| Inspection ID | 883912 |
|---|---|
| Firm | Tiger Medical Group |
| FEI number | 3004488394 |
| Address | Jaje Plaza Suite 703, 1717 Sichuanbeilu |
| City | Shanghai |
| Country | China |
| Fiscal year | 2014 |
| Inspection end date | May 22, 2014 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Postmarket Assurance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data